PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 317 shares of the stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $45.03, for a total value of $14,274.51. Following the completion of the transaction, the chief executive officer directly owned 54,555,249 shares of the company’s stock, valued at $2,456,622,862.47. This trade represents a 0.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The shares were sold at an average price of $45.23, for a total value of $476,226.67.
- On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total value of $396,098.36.
- On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total value of $206,164.14.
- On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The stock was sold at an average price of $43.49, for a total value of $1,046,238.93.
- On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The shares were sold at an average price of $42.69, for a total value of $984,943.68.
- On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The shares were sold at an average price of $42.56, for a total transaction of $858,562.88.
- On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The stock was sold at an average price of $42.94, for a total transaction of $1,021,242.02.
- On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The stock was sold at an average price of $42.39, for a total transaction of $1,024,015.23.
- On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The shares were sold at an average price of $43.90, for a total transaction of $2,600,811.60.
- On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The shares were sold at an average price of $43.92, for a total transaction of $4,010,159.52.
PACS Group Price Performance
Shares of PACS stock traded down $0.15 during midday trading on Monday, reaching $44.61. 759,862 shares of the company were exchanged, compared to its average volume of 904,574. PACS Group, Inc. has a 12 month low of $9.69 and a 12 month high of $49.49. The company has a market cap of $7.06 billion, a P/E ratio of 25.93, a PEG ratio of 1.40 and a beta of -0.13. The company’s 50 day moving average price is $44.74 and its two-hundred day moving average price is $39.08. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91.
Institutional Investors Weigh In On PACS Group
Hedge funds have recently modified their holdings of the stock. Tidal Investments LLC acquired a new position in shares of PACS Group in the 2nd quarter valued at $252,000. Engineers Gate Manager LP acquired a new stake in PACS Group during the 2nd quarter worth about $1,132,000. Integrated Wealth Concepts LLC acquired a new stake in PACS Group during the 2nd quarter worth about $75,000. Squarepoint Ops LLC lifted its stake in PACS Group by 94.7% during the second quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock valued at $2,538,000 after buying an additional 28,945 shares in the last quarter. Finally, Nykredit A S purchased a new stake in PACS Group during the second quarter valued at about $95,000.
Wall Street Analyst Weigh In
Several brokerages have commented on PACS. Royal Bank Of Canada boosted their price target on shares of PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. lifted their price objective on shares of PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Weiss Ratings downgraded shares of PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th. Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Oppenheimer raised their target price on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Five analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $58.80.
View Our Latest Report on PACS
About PACS Group
PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.
The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.
Further Reading
- Five stocks we like better than PACS Group
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
